A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c
Clinical trial NCT03048253 · UNKNOWN
Trial details
- NCT number
- NCT03048253
- Sponsor
- OrienGene Biotechnology Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-03-29
- Primary completion
- 2017-10-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.